| 2026-08-05 | Press release | Press Release |
| 2026-08-04 | Press release | Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand |
| 2026-07-22 | Press release | Evolus to Report Second Quarter Financial Results on August 5, 2026 |
| 2026-07-10 | Press release | Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-07-08 | Press release | Download PDF, Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United |
| 2026-06-04 | Press release | Evolus to Participate in The Jefferies Global Healthcare Conference |
| 2026-05-19 | Press release | Download PDF, Evolus to Participate in The Jefferies Global Healthcare Conference, May 19, 2026, (opens in new window) |
| 2026-05-11 | Press release | Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe |
| 2026-05-04 | Press release | Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EB |
| 2026-05-04 | Presentation | Download PDF file, (opens in new window) |
| 2026-05-04 | Press release | Press Release
of Q1 2026, PDF file, (opens in new window) |
| 2026-04-14 | Press release | Evolus to Report First Quarter Financial Results on May 4, 2026 |
| 2026-04-14 | Press release | Evolus to Report First Quarter Financial Results on May 4, 2026 |
| 2026-04-14 | Press release | Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference |
| 2026-03-31 | Press release | Download PDF, Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference, March 31, 2026, (opens in |
| 2026-03-20 | Press release | Download PDF, Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), March 20, 2026, (opens in new windo |
| 2026-03-11 | Press release | Evolus to Participate in The Leerink Partners Global Healthcare Conference |
| 2026-03-03 | Press release | Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Grow |
| 2026-03-03 | Press release | Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Grow |
| 2026-02-25 | Press release | Download PDF, Evolus to Participate in The Leerink Partners Global Healthcare Conference, February 25, 2026, (opens in n |
| 2026-02-17 | Press release | Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026 |
| 2026-02-17 | Press release | Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026 |
| 2026-02-13 | Press release | Download PDF, Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), February 13, 2026, (opens in new wi |
| 2026-01-09 | Press release | Download PDF, Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue, January 9, 2026, (op |
| 2026-01-02 | Presentation | Download PDF (opens in new window) |
| 2025-11-05 | Quarterly report | View full release of Q3 2025 Earnings, (opens in new window) |
| 2025-08-05 | Quarterly report | View full release of Q2 2025 Earnings, (opens in new window) |
| 2025-03-04 | Press release | Q4 |
| 2024-11-06 | Press release | Q3 |
| 2024-07-31 | Press release | Q2 |
| 2024-05-07 | Press release | Q1 |
| 2024-03-07 | Press release | Q4 |
| 2023-11-07 | Press release | Q3 |
| 2023-08-02 | Press release | Q2 |
| 2023-05-09 | Press release | Q1 |
| 2023-03-08 | Press release | Q4 |
| 2022-11-08 | Press release | Q3 |
| 2022-08-02 | Press release | Q2 |
| 2022-05-10 | Press release | Q1 |
| 2022-03-03 | Press release | Q4 |